本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Olema Pharmaceuticals, Inc.

5.46
-0.0600-1.09%
盘后5.460.00000.00%18:51 EDT
成交量:30.30万
成交额:165.81万
市值:3.75亿
市盈率:-2.82
高:5.64
开:5.52
低:5.39
收:5.52
52周最高:13.93
52周最低:2.86
股本:6,863.43万
流通股本:3,964.53万
量比:1.08
换手率:0.76%
股息:- -
股息率:- -
每股收益(TTM):-1.9357
每股收益(LYR):-2.2041
净资产收益率:-49.72%
总资产收益率:-29.87%
市净率:1.09
市盈率(LYR):-2.48

数据加载中...

公司资料

公司名字:
Olema Pharmaceuticals, Inc.
交易所:
NASDAQ
成立时间:
2006
员工人数:
117
公司地址:
780 Brannan Street,San Francisco,California,United States
邮编:
94103
电话:
传真:
- -
简介:
Olema Pharmaceuticals, Inc.位于加利福尼亚州的旧金山,于2006年8月7日在特拉华州注册成立。该公司是一家临床阶段的生物制药公司,致力于发现,开发和商业化针对女性癌症的下一代靶向疗法。

董事

名称
职位
Sean Bohen
President, Chief Executive Officer and Director
Cyrus L. Harmon
Chief Technology Officer and Director
Ian Clark
Chairperson of the Board of Director
Andrew Rappaport
Director
Cynthia Butitta
Director
Frank McCormick
Director
Gorjan Hrustanovic
Director
Graham Walmsley
Director
Sandra Horning
Director

股东

名称
职位
Sean Bohen
President, Chief Executive Officer and Director
Cyrus L. Harmon
Chief Technology Officer and Director
David C. Myles
Chief Development Officer
John B. Moriarty, Jr.
Executive Vice President, Chief Legal Officer and Corporate Secretary
Kinney Horn
Chief Business Officer
Peter J. Kushner
Chief Scientific Officer
Shane Kovacs
Chief Operating and Financial Officer